第八节 展 望
拉沙热现阶段只是在西非地区爆发和流行,越来越多传播实例证明拉沙热存在着跨境传播的风险。截至目前,我国尚未发现拉沙热的输入性病例,随着我国飞速发展,我国与非洲国家之间的贸易规模越来越大,我们与之的合作关系越来越密切,人员往来越来越复杂,我国公民感染拉沙热的风险也会越来越大。因此,我们不能放松警惕,应时刻做好拉沙热以及其他输入性疾病的防控,及时发现输入病例,杜绝二次传播。虽然类似拉沙热之类的传染性疾病让人恐慌,但纵观人类史上的每一次与疾病的较量,都是人类取得了最后的胜利。随着科学技术的不断进步,人类对抗包括拉沙热在内的传染性疾病的技术手段也会越来越成熟,相信在不久的将来,人类能攻克包括拉沙热在内的诸多传染性疾病。
(彭靖尧)
参考文献
[1]Happi A N,Happi C T,Schoepp R J.Lassa fever diagnostics:past,present,and future[J].Curr Opin Virol,2019,37:132-138.
[2]Iannetta M,Di Caro A,Nicastri E,et al.Viral hemorrhagic fevers other than ebola and lassa[J].infect Dis Clin North Am,2019,33 (4) :977-1002.
[3]Houlihan C,Behrens R.Lassa fever[J].Bmj,2017,358:j2986.
[4]Fernandes J,De Oliveira R C,Guterres A,et al.Co-circulation of clade C new world Arenaviruses:New geographic distribution and host species[J].Infect Genet Evol,2015,33:242-245.
[5]Ly H.Differential immune responses to new world and old world mammalian arenaviruses[J].Int J Mol Sci,2017,18 (5) ,1040.
[6]Radoshitzky S R,Buchmeier M J,Charrel R N,et al.ICTV Virus Taxonomy Profile:Arenaviridae[J].J Gen Virol,2019,100 (8) :1200-1201.
[7]Shi M,Lin X D,Chen X,et al.The evolutionary history of vertebrate RNA viruses[J].Nature,2018,556 (7700) :197-202.
[8]Garry R F.50Years of Lassa Fever Research[J].Curr Top Microbiol Immunol,2020,10:1007.
[9]Pontremoli C,Forni D,Sironi M.Arenavirus genomics:novel insights into viral diversity,origin,and evolution[J].Curr Opin Virol,2019,34:18-28.
[10]West B R,Hastie K M,Saphire E O.Structure of the LCMV nucleoprotein provides a template for understanding arenavirus replication and immunosuppression[J].Acta Crystallogr D Biol Crystallogr,2014,70 (Pt 6) :1764-1769.
[11]Bederka L H,Bonhomme C J,Ling E L,et al.Arenavirus stable signal peptide is the keystone subunit for glycoprotein complex organization[J].mBio,2014,5 (6) :e02063.
[12]Hastie K M,Zandonatti M,Liu T,et al.Crystal structure of the oligomeric form of lassa virus matrix protein Z[J].J Virol,2016,90 (9) :4556-4562.
[13]Shao J,Liang Y,Ly H.Roles of arenavirus Z protein in mediating virion budding,viral transcription-inhibition and interferon-beta suppression[J].Methods Mol Biol,2018,1604:217-227.
[14]Ohanu M E,Nwafia I N.Lassa fever:Time to eradicate the deadly disease in Nigeria[J].Niger J Clin Pract,2019,22 (1) :144-145.
[15]Hass M,Westerkofsky M,Müller S,et al.Mutational analysis of the lassa virus promoter[J].J Virol,2006,80 (24) :12414-12419.
[16]Radoshitzky S R,Bào Y,Buchmeier M J,et al.Past,present,and future of arenavirus taxonomy[J].Arch Virol,2015,160 (7) :1851-1874.
[17]Olayemi A,Cadar D,Magassouba N,et al.New hosts of the lassa virus[J].Sci Rep,2016,6:25280.
[18]Andersen K G,Shylakhter I,Tabrizi S,et al.Genome-wide scans provide evidence for positive selection of genes implicated in Lassa fever[J].Philos Trans R Soc Lond B Biol Sci,2012,367 (1590) :868-877.
[19]Fichet-Calvet E,Becker-Ziaja B,Koivogui L,et al.Lassa serology in natural populations of rodents and horizontal transmission[J].Vector Borne Zoonotic Dis,2014,14 (9) :665-674.
[20]Lecompte E,Fichet-Calvet E,Daffis S,et al.Mastomys natalensis and Lassa fever[J].West Africa.Emerg Infect Dis,2006,12 (12) :1971-1974.
[21]Bonwitt J,Kelly A H,Ansumana R,et al.Rat-atouille:A Mixed Method Study to Characterize Rodent Hunting and Consumption in the Context of Lassa Fever[J].Ecohealth,2016,13 (2) :234-247.
[22]Fisher-Hoch S P.Lessons from nosocomial viral haemorrhagic fever outbreaks[J].Br Med Bull,2005,73-74:123-137.
[23]Lo Iacono G,Cunningham A A,Fichet-Calvet E,et al.Using modelling to disentangle the relative contributions of zoonotic and anthroponotic transmission:the case of lassa fever[J].PLoS Negl Trop Dis,2015,9 (1) :e3398.
[24]Drosten C,Kümmerer B M,Schmitz H,et al.Molecular diagnostics of viral hemorrhagic fevers[J].Antiviral Res,2003,57 (1-2) :61-87.
[25]Helmick C G,Webb P A,Scribner C L,et al.No evidence for increased risk of Lassa fever infection in hospital staff[J].Lancet,1986,2 (8517) :1202-1205.
[26]Salam A P,Horby P W.The breadth of viruses in Human Semen[J].Emerg Infect Dis,2017,23 (11) :1922-1924.
[27]Feldmann H.Virus in semen and the risk of sexual transmission[J].N Engl J Med,2018,378 (15) :1440-1441.
[28]Mari
n J,Sluydts V,Borremans B,et al.Arenavirus infection correlates with lower survival of its natural rodent host in a long-term capture-mark-recapture study[J].Parasit Vectors,2018,11 (1) :90.
[29]Kayem N D,Benson C,Aye C Y L,et al.Lassa fever in pregnancy:a systematic review and meta-analysis[J].Trans R Soc Trop Med Hyg,2020,114 (5) :385-396.
[30]Gibb R,Moses L M,Redding D W,et al.Understanding the cryptic nature of Lassa fever in West Africa[J].Pathog Glob Health,2017,111 (6) :276-288.
[31]Russier M,Pannetier D,Baize S.Immune responses and Lassa virus infection[J].Viruses,2012,4 (11) :2766-2785.
[32]Fisher-Hoch S,Mccormick J B,Sasso D,et al.Hematologic dysfunction in Lassa fever[J].J Med Virol,1988,26 (2) :127-135.
[33]Bonwitt J,Sáez A M,Lamin J,et al.At home with mastomys and Rattus:human-rodent interactions and potential for primary transmission of Lassa Virus in Domestic Spaces[J].Am J Trop Med Hyg,2017,96 (4) :935-943.
[34]Mylne A Q,Pigott D M,Longbottom J,et al.Mapping the zoonotic niche of Lassa fever in Africa[J].Trans R Soc Trop Med Hyg,2015,109 (8) :483-492.
[35]Ter Meulen J,Lukashevich I,Sidibe K,et al.Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea[J].Am J Trop Med Hyg,1996,55 (6) :661-666.
[36]Akhmetzhanov A R,Asai Y,Nishiura H.Quantifying the seasonal drivers of transmission for Lassa fever in Nigeria[J].Philos Trans R Soc Lond B Biol Sci,2019,374 (1775) :20180268.(https://www.daowen.com)
[37]Awosanya E J.Post-epidemic awareness and knowledge of Lassa fever among residents in affected community in Ibadan,Oyo State,Nigeria[J].Vet World,2018,11 (8) :1059-1063.
[38]Bond N,Schieffelin J S,Moses L M,et al.A historical look at the first reported cases of Lassa fever:IgG antibodies 40 years after acute infection[J].Am J Trop Med Hyg,2013,88 (2) :241-244.
[39]Andersen K G,Shapiro B J,Matranga C B,et al.clinical Sequencing uncovers origins and evolution of Lassa Virus[J].Cell,2015,162 (4) :738-750.
[40]Brosh-Nissimov T.Lassa fever:another threat from West Africa[J].Disaster Mil Med,2016,2:8.
[41]Maxmen A.Deadly Lassa-fever outbreak tests Nigeria′s revamped health agency[J].Nature,2018,555 (7697) :421-422.
[42]Ilori E A,Furuse Y,Ipadeola O B,et al.Epidemiologic and Clinical Features of lassa fever outbreak in Nigeria,January 1-May 6,2018[J].Emerg Infect Dis,2019,25 (6) :1066-1074.
[43]Ezeomah C,Adoga A,Ihekweazu C,et al.Sequelae of Lassa Fever:Postviral cerebellar ataxia[J].open Forum Infect Dis,2019,6 (12) :ofz512.
[44]Ehlkes L,George M,Samosny G,et al.Management of a Lassa fever outbreak,Rhineland-Palatinate,Germany,2016.Euro Surveill,2017,22 (39) :16-00728.
[45]Grahn A,Br
ve A,Lagging M,et al.Imported case of Lassa fever in Sweden with encephalopathy and sensorineural hearing Deficit[J].Open Forum Infect Dis,2016,3 (4) :ofw198.
[46]Safronetz D,Sogoba N,Lopez J E,et al.Geographic distribution and genetic characterization of Lassa virus in sub-Saharan Mali[J].PLoS Negl Trop Dis,2013,7 (12) :e2582.
[47]Asogun D A,Günther S,Akpede G O,et al.Lassa Fever:Epidemiology,Clinical Features,Diagnosis,Management and Prevention[J].Infect Dis Clin North Am,2019,33 (4) :933-951.
[48]Ilori E A,Frank C,Dan-Nwafor C C,et al.Increase in Lassa Fever Cases in Nigeria,January-March 2018[J].Emerg Infect Dis,2019,25 (5) :1026-1027.
[49]Siddle K J,Eromon P,Barnes K G,et al.Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018[J].N Engl J Med,2018,379 (18) :1745-1753.
[50]Ehichioya D U,Hass M,Olschl
ger S,et al.Lassa fever,Nigeria,2005-2008[J].Emerg Infect Dis,2010,16 (6) :1001-1004.
[51]Purushotham J,Lambe T,Gilbert S C.Vaccine platforms for the prevention of Lassa fever[J].Immunol Lett,2019,215:1-11.
[52]Yun N E,Walker D H.Pathogenesis of Lassa fever.Viruses,2012,4 (10) :2031-2048.
[53]Jae L T,Raaben M,Herbert A S,et al.Virus entry.Lassa virus entry requires a trigger-induced receptor switch[J].Science,2014,344 (6191) :1506-1510.
[54]Li S,Sun Z,Pryce R,et al.Acidic pH-Induced Conformations and LAMP1 Binding of the Lassa Virus Glycoprotein Spike[J].PLoS Pathog,2016,12 (2) :e1005418.
[55]Torriani G,Galan-Navarro C,Kunz S.Lassa Virus Cell Entry Reveals New Aspects of Virus-Host Cell Interaction[J].J Virol,2017,91 (4) :e01902-16.
[56]Schaeffer J,Carnec X,Reynard S,et al.Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells[J].PLoS Pathog,2018,14 (11) :e1007430.
[57]Baize S,Kaplon J,Faure C,et al.Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells[J].J Immunol,2004,172 (5) :2861-2869.
[58]Yun N E,Poussard A L,Seregin A V,et al.Functional interferon system is required for clearance of lassa virus[J].J Virol,2012,86 (6) :3389-3392.
[59]Oestereich L,Lüdtke A,Ruibal P,et al.Chimeric mice with competent hematopoietic immunity reproduce key features of severe lassa fever[J].PLoS Pathog,2016,12 (5) :e1005656.
[60]Baize S,Marianneau P,Loth P,et al.Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys[J].J Virol,2009,83 (11) :5890-5903.
[61]Flatz L,Rieger T,Merkler D,et al.T cell-dependence of Lassa fever pathogenesis[J].PLoS Pathog,2010,6 (3) :e1000836.
[62]Akpede G O,Asogun D A,Okogbenin S A,et al.Lassa fever outbreaks in Nigeria[J].Expert Rev Anti Infect Ther,2018,16 (9) :663-666.
[63]Okokhere P,Colubri A,Azubike C,et al.Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria:a retrospective,observational cohort study[J].Lancet Infect Dis,2018,18 (6) :684-695.
[64]Ibekwe T.Lassa fever:the challenges of curtailing a deadly disease[J].Pan Afr Med J,2012,11:55.
[65]Cross R W,Hastie K M,Mire C E,et al.Antibody therapy for Lassa fever[J].Curr Opin Virol,2019,37:97-104.
[66]Raabe V,Koehler J.Laboratory Diagnosis of Lassa Fever.J Clin Microbiol,2017,55 (6) :1629-1637.
[67]Bausch D G,Rollin P E,Demby A H,et al.Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay,indirect fluorescent-antibody test,and virus isolation[J].J Clin Microbiol,2000,38 (7) :2670-2677.
[68]Drosten C,G
ttig S,Schilling S,et al.Rapid detection and quantification of RNA of ebola and marburg viruses,lassa virus,Crimean-Congo hemorrhagic fever virus,Rift Valley fever virus,dengue virus,and yellow fever virus by real-time reverse transcription-PCR[J].J Clin Microbiol,2002,40 (7) :2323-2330.
[69]Vieth S,Drosten C,Lenz O,et al.RT-PCR assay for detection of Lassa virus and related Old World arenaviruses targeting the L gene[J].Trans R Soc Trop Med Hyg,2007,101 (12) :1253-1264.
[70]Branco L M,Grove J N,Boisen M L,et al.Emerging trends in Lassa fever:redefining the role of immunoglobulin M and inflammation in diagnosing acute infection[J].Virol J,2011,8:478.
[71]Satterly N G,Voorhees M A,Ames A D,et al.Comparison of mag Pix assays and enzyme-linked immunosorbent assay for detection of hemorrhagic fever viruses[J].J Clin Microbiol,2017,55 (1) :68-78.
[72]Salami K,Gouglas D,Schmaljohn C,et al.A review of Lassa fever vaccine candidates[J].Curr Opin Virol,2019,37:105-111.
[73]Warner B M,Safronetz D,Stein D R.Current research for a vaccine against Lassa hemorrhagic fever virus[J].Drug Des Devel Ther,2018,12:2519-2527.
[74]Kofman A,Choi M J,Rollin P E.Lassa Fever in Travelers from West Africa,1969-2016[J].Emerg Infect Dis,2019,25 (2) :245-248.
[75]Lehmann C,Kochanek M,Abdulla D,et al.Control measures following a case of imported Lassa fever from Togo,North Rhine Westphalia,Germany,2016[J].Euro Surveill,2017,22 (39) :17-88.